Please Wait.....
Report
Canada Specialty Pharmacy Market - Industry Trends and Forecast to 2030
Market Report I 2022-11-01 I 165 Pages I Data Bridge Market Research
The Canada specialty pharmacy market is projected to register a substantial CAGR of 10.7% in the forecast period of 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.
Market Segmentation:
Canada Specialty Pharmacy Market, By Service Type (Clinical Services, Operational Services, and Other Services), Type (Large Pharmacy Benefit Manager and Small- Independent Pharmacy Service Providers), Condition (Anemia, Cancer, HIV, Infertility, Multiple Sclerosis, Rheumatoid Arthritis, Growth Hormone Deficiencies, Hepatitis C Virus, Hemophilia, Psoriasis, Pulmonary Hypertension, Crohn's Disease, Cystic Fibrosis, Immune Deficiency, Osteoarthritis, Juvenile Idiopathic Arthritis, Ulcerative Colitis, and others) Industry Trends and Forecast To 2030
Some of the major factors contributing to the growth of Canada specialty pharmacy market are:
- Increasing geriatric population
- Increasing prevalence of chronic and rare diseases
Market Players:
Some of the major players operating in the Canada specialty pharmacy market are:
- NKS Health (a Subsidiary of Green Shield)
- Concord Specialty Pharmacy
- BioScript Solutions
- McKesson Canada
- Bayshore HealthCare
- SRx Health
- Sentrex Health Solutions
- PHARMASAVE
- Lovell Drugs
- Create Compounding Ltd.
- Dynasty Pharmacy
- Resident Care Pharmacy
- Pace Pharmacy
- Northmount Pharmacy and Compounding Lab
- Medicine Centre
- riverviewguardian.ca
- Brunskillpharmacy
- Extend Pharmacy
- Sherman Specialty Pharmacy
- Quiick Medicine
- Allcures Pharmacy
- Alpine Drug Mart I.D.A.
- PharmaChoiceAnchor Compounding Pharmacy
- Andreen's Pharmacy
- Balanced Health Integrative Pharmacy
- Bains Pharmacy
- Shoppers Drug Mart Specialty Health Network Inc.
- MEDS PHARMACY
- Rx Connect
- London Drugs
- Aurora Health Care
- Omnicell Inc.
- Sobeys Inc.
- Rexall Pharmacy Group ULC
- Onpharm United
- Mountain Health CO-OP
- City Life Pharmacy & Compounding Centre
- Compounding Pharmacy New Westminster- Longevity Pharmacy
- VICTORIA COMPOUNDING PHARMACY
- Aaronson's Compounding Pharmacy
- TOTAL PHARMACY
- Pratt's Compounding Pharmacy
- Medlandia.Com
- Omnicare Pharmacy
- Budget Pharmacy
- Torani and Haddad Pharmacy Spec-Pharma
- West End Pharmacy
- 360Care Denman Pharmacy
- McCallum Pharmacy
- ABBY PHARMACY
- PharmaChoice
TABLE OF CONTENTS
1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.3 OVERVIEW OF THE CANADA SPECIALTY PHARMACY MARKET 14
1.4 LIMITATIONS 15
1.5 MARKETS COVERED 16
2 MARKET SEGMENTATION 18
2.1 MARKETS COVERED 18
2.2 GEOGRAPHICAL SCOPE 19
2.3 YEARS CONSIDERED FOR THE STUDY 19
2.4 CURRENCY AND PRICING 19
2.5 DBMR TRIPOD DATA VALIDATION MODEL 20
2.6 MULTIVARIATE MODELLING 23
2.7 SERVICE TYPE LIFELINE CURVE 23
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 24
2.9 DBMR MARKET POSITION GRID 25
2.10 VENDOR SHARE ANALYSIS 27
2.11 SECONDARY SOURCES 28
2.12 ASSUMPTIONS 28
3 EXECUTIVE SUMMARY 29
4 PREMIUM INSIGHTS 32
4.1 PORTER'S FIVE FORCES 33
4.2 PESTEL ANALYSIS 34
4.3 CANADA SPECIALTY PHARMACY MARKET, DISTRIBUTION MODEL 35
4.4 CANADA SPECIALTY PHARMACY MARKET, KEY STRATEGIC INITIATIVES 38
4.5 CANADA SPECIALTY PHARMACY MARKET, PATIENT ASSISTANCE PROGRAMS IN CANADA 39
4.6 CANADA SPECIALTY PHARMACY MARKET, INDUSTRY INSIGHTS 41
4.7 CANADA SPECIALTY PHARMACY MARKET, REGULATIONS 42
5 LIST OF SMALL ENTERPRISES 44
6 EPIDEMEOLOGY 50
7 COUNTRY WRITE-UP 60
8 MARKET OVERVIEW 61
8.1 DRIVERS 63
8.1.1 INCREASING PREVALENCE OF CHRONIC AND RARE DISEASES 63
8.1.2 INCREASING GERIATRIC POPULATION 64
8.1.3 INSURANCE COVERAGE 65
8.1.4 INCREASING NUMBER OF DISTRIBUTION CHANNELS FOR SPECIALITY DRUGS 66
8.2 RESTRAINTS 67
8.2.1 STRINGENT REGULATORY FRAMEWORK 67
8.2.2 LACK OF SKILLED PHARMACISTS 67
8.3 OPPORTUNITIES 68
8.3.1 EMERGING MARKETS OF SPECIALTY PHARMACIES 68
8.3.2 RISING E-PHARMACIES FACILITIES 69
8.4 CHALLENGES 70
8.4.1 LACK OF AWARENESS AMONG CONSUMERS ABOUT SPECIALTY PHARMACIES 70
8.4.2 INSUFFICIENT FUNDING FOR SPECIALITY PHARMACIES 70
9 CANADA SPECIALTY PHARMACY MARKET, BY SERVICE TYPE 71
9.1 OVERVIEW 72
9.2 CLINICAL SERVICES 76
9.2.1 COMPOUNDING 77
9.2.2 AUTO-REFILLS/REFILLS 77
9.2.3 BLISTER PACKAGING 77
9.2.4 MEDICAL CONSULTATIONS 78
9.2.4.1 PATIENT SIDE EFFECTS 78
9.2.4.2 ADVERSE DRUG REACTIONS 78
9.2.4.3 NON-COMPLIANCE 78
9.2.4.4 OTHER PATIENT CONCERNS 78
9.2.5 CARE MANAGEMENT 79
9.2.6 PATIENT ADHERENCE PROGRAMS 79
9.2.7 HEALTH CARE PROVIDER ACCESS 79
9.2.8 CLINICAL OUTCOME MEASURES 79
9.2.9 RISK EVALUATION AND MITIGATION STRATEGIES (REMS) PROGRAMS 79
9.2.9.1 REMS REPORTING 79
9.2.9.2 PHASE IV TRIALS 79
9.2.9.3 CLINICAL AND COGNITIVE COUNSELING 80
9.3 OPERATIONAL SERVICES 80
9.3.1 SUPPLY CHAIN MANAGEMENT 81
9.3.1.1 STORAGE & HANDLING 81
9.3.1.2 DISTRIBUTION 81
9.3.2 CARE COORDINATION 81
9.3.3 INSURANCE NAVIGATION 81
9.3.3.1 UTILIZATION MANAGEMENT 82
9.3.3.2 PRIOR AUTHORIZATION PROCESSES 82
9.3.4 PATIENT ASSISTANCE 82
9.3.5 PLAN OPTIMIZATION 82
9.4 OTHER SERVICES 83
10 CANADA SPECIALTY PHARMACY MARKET, BY TYPE 84
10.1 OVERVIEW 85
10.2 LARGE PHARMACY BENEFIT MANAGER (PBM) 89
10.2.1 MANUFACTURER-OWNED SPECIALTY PHARMACIES 89
10.2.2 OWNED SPECIALTY PHARMACIES 89
10.3 SMALL INDEPENDENT PHARMACY SERVICE PROVIDERS 89
11 CANADA SPECIALTY PHARMACY MARKET, BY CONDITION 91
11.1 OVERVIEW 92
11.2 CANCER 97
11.3 RHEUMATOID ARTHRITIS 97
11.4 MULTIPLE SCLEROSIS 98
11.5 OSTEOARTHRITIS 98
11.6 INFERTILITY 99
11.7 HIV 99
11.8 PULMONARY HYPERTENSION 99
11.9 IMMUNE DEFICIENCY 100
11.10 ANEMIA 100
11.11 HEMOPHILIA 101
11.12 PSORIASIS 101
11.13 CYSTIC FIBROSIS 102
11.14 ULCERATIVE COLITIS 102
11.15 CROHN'S DISEASE 103
11.16 JUVENILE IDIOPATHIC ARTHRITIS 103
11.17 GROWTH HORMONE DEFICIENCIES 104
11.18 HEPATITIS C VIRUS 104
11.19 OTHERS 105
12 CANADA SPECIALTY PHARMACY MARKET, COMPANY LANDSCAPE 106
12.1 COMPANY SHARE ANALYSIS: CANADA 106
13 SWOT ANALYSIS 107
14 COMPANY PROFILES 108
14.1 BAYSHORE HEALTHCARE 108
14.1.1 COMPANY SNAPSHOT 108
14.1.2 PRODUCT PORTFOLIO 108
14.1.3 RECENT DEVELOPMENTS 108
14.2 MCKESSON CANADA 109
14.2.1 COMPANY SNAPSHOT 109
14.2.2 PRODUCT PORTFOLIO 109
14.2.3 RECENT DEVELOPMENTS 109
14.3 SOBEYS INC. 110
14.3.1 COMPANY SNAPSHOT 110
14.3.2 PRODUCT PORTFOLIO 110
14.3.3 RECENT DEVELOPMENTS 110
14.4 AURORA HEALTH CARE 111
14.4.1 COMPANY SNAPSHOT 111
14.4.2 PRODUCT PORTFOLIO 111
14.4.3 RECENT DEVELOPMENTS 111
14.5 REXALL PHARMACY GROUP ULC 112
14.5.1 COMPANY SNAPSHOT 112
14.5.2 PRODUCT PORTFOLIO 112
14.5.3 RECENT DEVELOPMENTS 112
14.6 ANDREEN'S PHARMACY 113
14.6.1 COMPANY SNAPSHOT 113
14.6.2 PRODUCT PORTFOLIO 113
14.6.3 RECENT DEVELOPMENTS 113
14.7 ALPINE DRUG MART I.D.A. 114
14.7.1 COMPANY SNAPSHOT 114
14.7.2 PRODUCT PORTFOLIO 114
14.7.3 RECENT DEVELOPMENTS 114
14.8 ALLCURES PHARMACY 115
14.8.1 COMPANY SNAPSHOT 115
14.8.2 PRODUCT PORTFOLIO 115
14.8.3 RECENT DEVELOPMENTS 115
14.9 ABBY PHARMACY 116
14.9.1 COMPANY SNAPSHOT 116
14.9.2 PRODUCT PORTFOLIO 116
14.9.3 RECENT DEVELOPMENTS 116
14.10 AARONSON'S COMPOUNDING PHARMACY 117
14.10.1 COMPANY SNAPSHOT 117
14.10.2 PRODUCT PORTFOLIO 117
14.10.3 RECENT DEVELOPMENTS 117
14.11 BALANCED HEALTH INTEGRATIVE PHARMACY 118
14.11.1 COMPANY SNAPSHOT 118
14.11.2 PRODUCT PORTFOLIO 118
14.11.3 1.11. 3 RECENT DEVELOPMENTS 118
14.12 BRUNSKILLPHARMACY 119
14.12.1 COMPANY SNAPSHOT 119
14.12.2 PRODUCT PORTFOLIO 119
14.12.3 RECENT DEVELOPMENTS 119
14.13 BUDGET PHARMACY 120
14.13.1 COMPANY SNAPSHOT 120
14.13.2 PRODUCT PORTFOLIO 120
14.13.3 RECENT DEVELOPMENTS 120
14.14 BIOSCRIPT SOLUTIONS 121
14.14.1 COMPANY SNAPSHOT 121
14.14.2 PRODUCT PORTFOLIO 121
14.14.3 RECENT DEVELOPMENT 121
14.15 BAINS PHARMACY 122
14.15.1 COMPANY SNAPSHOT 122
14.15.2 PRODUCT PORTFOLIO 122
14.15.3 RECENT DEVELOPMENTS 122
14.16 360CARE DENMAN PHARMACY 123
14.16.1 COMPANY SNAPSHOT 123
14.16.2 PRODUCT PORTFOLIO 123
14.16.3 RECENT DEVELOPMENTS 123
14.17 COMPOUNDING PHARMACY NEW WESTMINSTER- LONGEVITY PHARMACY 124
14.17.1 COMPANY SNAPSHOT 124
14.17.2 PRODUCT PORTFOLIO 124
14.17.3 RECENT DEVELOPMENTS 124
14.18 CITY LIFE PHARMACY & COMPOUNDING CENTRE 125
14.18.1 COMPANY SNAPSHOT 125
14.18.2 PRODUCT PORTFOLIO 125
14.18.3 RECENT DEVELOPMENTS 125
14.19 CREATE COMPOUNDING LTD. 126
14.19.1 COMPANY SNAPSHOT 126
14.19.2 PRODUCT PORTFOLIO 126
14.19.3 RECENT DEVELOPMENTS 126
14.20 CONCORD SPECIALTY PHARMACY 127
14.20.1 COMPANY SNAPSHOT 127
14.20.2 PRODUCT PORTFOLIO 127
14.20.3 1.20.3RECENT DEVELOPMENTS 127
14.21 DYNASTY PHARMACY 128
14.21.1 COMPANY SNAPSHOT 128
14.21.2 PRODUCT PORTFOLIO 128
14.21.3 RECENT DEVELOPMENTS 128
14.22 EXTEND PHARMACY 129
14.22.1 COMPANY SNAPSHOT 129
14.22.2 PRODUCT PORTFOLIO 129
14.22.3 RECENT DEVELOPMENTS 129
14.23 LOVELL DRUGS 130
14.23.1 COMPANY SNAPSHOT 130
14.23.2 PRODUCT PORTFOLIO 130
14.23.3 RECENT DEVELOPMENTS 130
14.24 LONDON DRUGS 131
14.24.1 COMPANY SNAPSHOT 131
14.24.2 PRODUCT PORTFOLIO 131
14.24.3 RECENT DEVELOPMENT 131
14.25 MCCALLUM PHARMACY 132
14.25.1 COMPANY SNAPSHOT 132
14.25.2 PRODUCT PORTFOLIO 132
14.25.3 RECENT DEVELOPMENTS 132
14.26 MEDLANDIA.COM 133
14.26.1 COMPANY SNAPSHOT 133
14.26.2 PRODUCT PORTFOLIO 133
14.26.3 RECENT DEVELOPMENTS 133
14.27 MEDICINE CENTRE 134
14.27.1 COMPANY SNAPSHOT 134
14.27.2 PRODUCT PORTFOLIO 134
14.27.3 RECENT DEVELOPMENTS 135
14.28 MOUNTAIN HEALTH CO-OP 136
14.28.1 COMPANY SNAPSHOT 136
14.28.2 PRODUCT PORTFOLIO 136
14.28.3 RECENT DEVELOPMENTS 136
14.29 MEDS PHARMACY 137
14.29.1 COMPANY SNAPSHOT 137
14.29.2 PRODUCT PORTFOLIO 137
14.29.3 RECENT DEVELOPMENTS 137
14.30 NORTHMOUNT PHARMACY AND COMPOUNDING LAB 138
14.30.1 COMPANY SNAPSHOT 138
14.30.2 PRODUCT PORTFOLIO 138
14.30.3 RECENT DEVELOPMENTS 138
14.31 NKS HEALTH (A SUBSIDIARY OF GREEN SHIELD) 139
14.31.1 COMPANY SNAPSHOT 139
14.31.2 PRODUCT PORTFOLIO 139
14.31.3 RECENT DEVELOPMENTS 139
14.32 ON-PHARM UNITED 140
14.32.1 COMPANY SNAPSHOT 140
14.32.2 PRODUCT PORTFOLIO 140
14.32.3 RECENT DEVELOPMENTS 140
14.33 OMNICARE PHARMACY 141
14.33.1 COMPANY SNAPSHOT 141
14.33.2 PRODUCT PORTFOLIO 141
14.33.3 RECENT DEVELOPMENTS 141
14.34 OMNICELL INC. (2022) 142
14.34.1 COMPANY SNAPSHOT 142
14.34.2 REVENUE ANALYSIS 142
14.34.3 PRODUCT PORTFOLIO 143
14.34.4 RECENT DEVELOPMENT 143
14.35 PHARMACHOICEANCHOR COMPOUNDING PHARMACY 144
14.35.1 COMPANY SNAPSHOT 144
14.35.2 PRODUCT PORTFOLIO 144
14.35.3 RECENT DEVELOPMENTS 144
14.36 PHARMACHOICE 145
14.36.1 COMPANY SNAPSHOT 145
146.2 PRODUCT PORTFOLIO 145
14.36.3 RECENT DEVELOPMENTS 145
14.37 PRATT'S COMPOUNDING PHARMACY 146
14.37.1 COMPANY SNAPSHOT 146
14.37.2 PRODUCT PORTFOLIO 146
14.37.3 RECENT DEVELOPMENTS 146
14.38 PHARMASAVE 147
14.38.1 COMPANY SNAPSHOT 147
14.38.2 PRODUCT PORTFOLIO 147
14.38.3 RECENT DEVELOPMENTS 147
14.39 PACE PHARMACY 148
14.39.1 COMPANY SNAPSHOT 148
14.39.2 PRODUCT PORTFOLIO 148
14.39.3 RECENT DEVELOPMENTS 148
14.40 QUIICK MEDICINE 149
14.40.1 COMPANY SNAPSHOT 149
14.40.2 PRODUCT PORTFOLIO 149
14.40.3 RECENT DEVELOPMENTS 149
14.41 RESIDENT CARE PHARMACY 150
14.41.1 COMPANY SNAPSHOT 150
14.41.2 PRODUCT PORTFOLIO 150
14.41.3 RECENT DEVELOPMENTS 150
14.42 RIVERVIEWGUARDIAN.CA 151
14.42.1 COMPANY SNAPSHOT 151
14.42.2 PRODUCT PORTFOLIO 151
14.42.3 RECENT DEVELOPMENTS 151
14.43 RX CONNECT 152
14.43.1 COMPANY SNAPSHOT 152
14.43.2 PRODUCT PORTFOLIO 152
14.43.3 RECENT DEVELOPMENTS 152
14.44 SRX HEALTH 153
14.44.1 COMPANY SNAPSHOT 153
14.44.2 PRODUCT PORTFOLIO 153
14.44.3 RECENT DEVELOPMENTS 154
14.45 SENTREX HEALTH SOLUTIONS 155
14.45.1 COMPANY SNAPSHOT 155
14.45.2 PRODUCT PORTFOLIO 155
14.45.3 RECENT DEVELOPMENTS 155
14.46 SHOPPERS DRUG MART SPECIALTY HEALTH NETWORK INC. 156
14.46.1 COMPANY SNAPSHOT 156
14.46.2 PRODUCT PORTFOLIO 156
14.46.3 RECENT DEVELOPMENTS 156
14.47 SHERMAN SPECIALTY PHARMACY 157
14.47.1 COMPANY SNAPSHOT 157
14.47.2 PRODUCT PORTFOLIO 157
14.47.3 RECENT DEVELOPMENTS 157
14.48 TORANI AND HADDAD PHARMACY SPEC- PHARMA 158
14.48.1 COMPANY SNAPSHOT 158
14.48.2 PRODUCT PORTFOLIO 158
14.48.3 RECENT DEVELOPMENTS 158
14.49 TOTAL PHARMACY 159
14.49.1 COMPANY SNAPSHOT 159
14.49.2 PRODUCT PORTFOLIO 159
14.49.3 RECENT DEVELOPMENTS 159
14.50 VICTORIA COMPOUNDING PHARMACY 160
14.50.1 COMPANY SNAPSHOT 160
14.50.2 PRODUCT PORTFOLIO 160
14.50.3 RECENT DEVELOPMENTS 160
14.51 WEST END PHARMACY 161
14.51.1 COMPANY SNAPSHOT 161
14.51.2 PRODUCT PORTFOLIO 161
14.51.3 RECENT DEVELOPMENTS 161
15 QUESTIONNAIRE 162
16 RELATED REPORTS 165
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security